First Prescription for COSELA® (trilaciclib) Issued in China

/PRNewswire/ -- Simcere Pharmaceutical Group Limited (2096.HK) ("Simcere"), an innovative global biopharmaceutical company, and G1 Therapeutics, Inc., (Nasdaq:...

Related Keywords

Jilin ,China ,United States ,Nanjing ,Jiangsu ,Chinese ,Tang Renhong ,Jack Bailey ,Simcere Pharmaceutical Group ,Nasdaq ,Prnewswire Simcere Pharmaceutical Group ,Therapeutics Inc ,Research Triangle Park ,National Comprehensive Cancer Network ,Chinese Society Of Clinical Oncology ,Jilin Cancer Hospital ,Pharmaceutical Group Limited ,Chief Executive Officer ,Executive Director ,Comprehensive Cancer ,Clinical Practice Guidelines ,Clinical Oncology ,New Drug Application ,Lung Cancer ,Simcere ,